University Of Stellenbosch
Clinical trials sponsored by University Of Stellenbosch, explained in plain language.
-
Could a common diabetes drug shield the brain in HIV patients?
Disease control CompletedThis pilot study tested whether metformin, a common diabetes drug, can reduce blood vessel damage and inflammation in the brain for people living with HIV who also have metabolic syndrome. Thirty adults on HIV treatment took metformin for 12 weeks, and researchers measured change…
Phase: PHASE2 • Sponsor: University of Stellenbosch • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Breakthrough test could save kids from deadly TB meningitis
Diagnosis CompletedThis study aimed to create a quick, point-of-care test to diagnose tuberculous meningitis (TBM) in children, a severe form of TB that affects the brain. Researchers analyzed blood and spinal fluid samples from 332 children to find the best combination of biomarkers. The goal was …
Sponsor: University of Stellenbosch • Aim: Diagnosis
Last updated May 26, 2026 10:08 UTC
-
ICU muscle loss: amino acid cocktail and cycling show promise
Knowledge-focused CompletedThis study tested whether giving critically ill patients extra amino acids through an IV and having them cycle while in bed could prevent muscle loss during their first week in the ICU. Half of the 50 participants received this combined treatment, while the other half got standar…
Phase: NA • Sponsor: University of Stellenbosch • Aim: Knowledge-focused
Last updated May 26, 2026 10:09 UTC